Evogene Announces Q2 2025 Financial Results Release, Schedules Zoom Conference Call for August 19, 2025.

Evogene will release its Q2 2025 financial results on August 19, 2025, and management will host a Zoom conference call at 9:00 AM ET. The company is a computational biology firm that uses AI to develop products through partnerships and subsidiaries, including Biomica, Lavie Bio, AgPlenus, and Casterra Ag.

Evogene Ltd. (NASDAQ: EVGN), a computational biology company focused on life-science product discovery and development, has announced that it will release its second-quarter 2025 financial results on Tuesday, August 19, 2025 [1][2]. The company will host a conference call to discuss the results at 9:00 AM ET (4:00 PM Israel time).

Interested participants are required to register in advance through the company's dedicated conference link. A recording of the conference will be made available on Evogene's website following the event.

Evogene is a leader in computational biology, leveraging big data and artificial intelligence to revolutionize life-science product development. The company's unique tech-engines, MicroBoost AI, ChemPass AI, and GeneRator AI, are focused on the discovery and development of products based on microbes, small molecules, and genetic elements, respectively. Through strategic partnerships and collaborations, Evogene develops products through its subsidiaries, including Biomica Ltd., Lavie Bio, AgPlenus Ltd., and Casterra Ag.

For more information, please visit Evogene's official website or contact the company at [ir@evogene.com](mailto:ir@evogene.com) or +972-8-9311901.

References:
[1] https://www.stocktitan.net/news/EVGN/evogene-schedules-second-quarter-2025-financial-results-ps3jfdih1evd.html
[2] https://evogene.com/press_release/evogene-schedules-second-quarter-2025-financial-results-release/